Pregnancy in women who have epilepsy

Neurologic Clinics

Volumn 22, Issue 4 SPEC. ISS., 2004, Pages 799-820

  Pennell, Page B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CONTRACEPTIVE AGENT; CYTOCHROME P450; DIAZEPAM; ENZYME; ETHOSUXIMIDE; ETIRACETAM; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; LEVONORGESTREL; LORAZEPAM; MEDROXYPROGESTERONE; METHYLPHENOBARBITAL; OXCARBAZEPINE; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; STEROID HORMONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; VITAMIN K GROUP; ZONISAMIDE;

ANEMIA; ANENCEPHALUS; AORTA COARCTATION; BIRTH CONTROL; BIRTH DEFECT; CESAREAN SECTION; CLEFT LIP; CLEFT PALATE; COGNITIVE DEFECT; CONCEPTION; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CRANIOFACIAL MALFORMATION; DELIVERY; DIET SUPPLEMENTATION; DISEASE CONTROL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXPOSURE; DRUG INDICATION; DRUG INHIBITION; DRUG MECHANISM; DRUG MILK LEVEL; DRUG MONITORING; DRUG SAFETY; DRUG WITHDRAWAL; ECLAMPSIA; EMBRYOTOXICITY; ENZYME INDUCTION; EPICANTHUS; EPILEPSY; FALLING; FALLOT TETRALOGY; FEMALE; FETUS MALFORMATION; FETUS RISK; FINGER MALFORMATION; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYDROCEPHALUS; HYPEREMESIS GRAVIDARUM; HYPERTELORISM; HYPOSPADIAS; INFANT MORTALITY; INTRAUTERINE GROWTH RETARDATION; LABOR; LABOR INDUCTION; LIP MALFORMATION; MENINGOMYELOCELE; MICROCEPHALY; MONOTHERAPY; NAIL HYPOPLASIA; NERVOUS SYSTEM DEVELOPMENT; NEURAL TUBE DEFECT; NEUROTOXICITY; NOSE MALFORMATION; ORAL CONTRACEPTION; ORGANOGENESIS; PATENT DUCTUS ARTERIOSUS; PATIENT COUNSELING; PREGNANCY; PREMATURE LABOR; PRENATAL EXPOSURE; PRENATAL SCREENING; PRIORITY JOURNAL; PUERPERIUM; PULMONARY VALVE STENOSIS; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SEIZURE; SOLUTIO PLACENTAE; SPINA BIFIDA; SUSTAINED RELEASE FORMULATION; TERATOGENICITY; UROGENITAL TRACT MALFORMATION; UTERUS CONTRACTION; VAGINA BLEEDING; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 4944246657     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2004.07.004     Document Type: Review

References (116)

1. K.J. Meador, and M.L. Zupanc Neurodevelopmental outcomes of children born to mothers with epilepsy Cleve Clin J Med 71 Suppl 2 2004 S38 S40
2. L.B. Holmes The teratogenecity of anticonvulsant drugs: a progress report J Med Genet 39 2002 245 247
3. S.D. Fairgrieve, M. Jackson, P. Jonas, D. Walshaw, K. White, and T.L. Montgomery Population based, prospective study of the care of women with epilepsy in pregnancy BMJ 321 2000 674 675
4. D. Janz, and D. Schmidt Anti-epileptic drugs and failure of oral contraceptives Lancet 1 1974 113
5. A. Guberman Hormonal contraception and epilepsy Neurology 53 Suppl 1 1999 S38 S40
6. Report of the Quality Standards Subcommittee of the American Academy of Neurology Practice parameter: management issues for women with epilepsy (summary statement) Neurology 51 1998 944 948
7. G. Krauss, J. Brandt, M. Campbell, C. Plate, and M. Summerfield Antiepileptic medication and oral contraceptive interactions: a national survey of neurologists and obstetricians Neurology 46 1996 1534 1539
8. W. Rosenfeld, D. Doose, S. Walker, and R. Nayak Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy Epilepsia 38 1997 317 323
9. L. Shane-McWhorter, J. Cerveny, L. MacFarlane, and C. Osborne Enhanced metabolism of levonorgestrel during phenobarbital treatment and resultant pregnancy Pharmacotherapy 18 1998 1360 1364
10. M.S. Yerby Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy Neurology 55 2000 21 31
11. C. Hvas, T. Henriksen, J. Ostergaard, and M. Dam Epilepsy and pregnancy: effect of antiepileptic drugs and lifestyle on birthweight Br J Obstet Gynaecol 107 2000 896 902
12. C. Arpino, S. Brescianini, and E. Robert Teratogenic effects of antiepileptic drugs: use of an international database on malformations and drug exposure (MADRE) Epilepsia 41 2000 1436 1443
13. P.B. Pennell The importance of monotherapy in pregnancy Neurology 60 11 Suppl 4 2003 S31 S38
14. K. Wide, B. Winbladh, T. Tomson, and B. Kallen Body dimensions of infants exposed to antiepileptic drugs in utero: observaitons spanning 25 years Epilepsia 41 2000 854 861
15. M. Morrell Guidelines for the care of women with epilepsy Neurology 51 Suppl 5 1998 S21 S27
16. M. Yerby, and O. Devinsky Epilepsy and pregnancy O. Devinsky E. Feldmann B. Hainline Advances in neurology: neurological complications of pregnancy 1994 Raven Press New York 45 63
17. C.A. Zahn, M.J. Morrell, S.D. Collins, D.M. Labiner, and M.S. Yerby Management issues for women with epilepsy: a review of the literature Neurology 51 1998 949 956
18. S. Kaneko, D. Battino, and E. Andermann Congenital malformations due to antiepileptic drugs Epilepsy Res 33 1999 145 158
19. E. Kaaja, R. Kaaja, and V. Hiilesmaa Major malformations in offspring of women with epilepsy Neurology 60 2003 575 579
20. D. Lindhout, J.G. Omtzigt, and M.C. Cornel Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs Neurology 42 4 Suppl 5 1992 111 118
21. J. Dean, H. Hailey, S. Moore, D. Lloyd, P. Turnpenny, and J. Little Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth J Med Genet 39 2002 251 259
22. C. Dravet, C. Julian, C. Legras, A. Magaudda, R. Guerrini, and P. Genton Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study Neurology 42 4 Suppl 5 1992 75 82
23. S. Kaneko, K. Otani, Y. Fukushima, Y. Ogawa, Y. Nomura, and T. Ono Teratogenicity of antiepileptic drugs: analysis of possible risk factors Epilepsia 29 1988 459 467
24. S. Kaneko, K. Otani, and Y. Fukushima Malformations in infants of mothers with epilepsy receiving antiepileptic drugs Neurology 42 Suppl 5 1992 68 74
25. D. Lindhout, H. Meinardi, J. Meijer, and H. Nau Antiepileptic drugs and teratogenesis in two consecutive cohorts: changes in prescription policy paralleled by changes in pattern of malformations Neurology 42 Suppl 5 1992 94 110
26. M. Oguni, L. Dansky, E. Andermann, A. Sherwin, and F. Andermann Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy [comment] Brain Dev 14 1992 371 380
27. E. Samrén, C. van Duijn, and S. Koch Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis asssociated with maternal epilepsy Epilepsia 38 1997 981 990
28. E. Samrén, C. van Duijn, G. Christiaens, A. Hofman, and D. Lindhout Antiepileptic drug regimens and major congenital abnormalities in the offspring Ann Neurol 46 1999 739 746
29. D. Lindhout, and J.G. Omtzigt Pregnancy and the risk of teratogenicity Epilepsia 33 Suppl 4 1992 41 48
30. M. Oguni, L. Dansky, E. Andermann, A. Sherwin, and F. Andermann Improved pregnancy outcome in epileptic women in the last decade: relationship to maternal anticonvulsant therapy [comment] Brain Dev 14 1992 371 380
31. C. Barrett, and A. Richens Epilepsy and pregnancy: report of an Epilepsy Research Foundation Workshop Epilepsy Res 52 2003 147 187
32. L.B. Holmes, E.A. Harvey, B.A. Coull, K.B. Huntington, S. Khoshbin, and A.M. Hayes The teratogenicity of anticonvulsant drugs N Engl J Med 344 2001 1132 1138
33. M. Lu, M. Sammel, R. Cleveland, L. Ryan, and L. Holmes Digit effects produced by prenatal exposure to antiepileptic drugs Teratology 61 2000 277 283
34. M. Sabry, and T. Farag Hand anomalies in fetal-hydantoin syndrome: from nail/phalangeal hypoplasia to unilateral acheiria Am J Med Genet 62 1996 410 412
35. F. Rosa Spina bifida in infants of women treated with carbamazepine during pregnancy N Engl J Med 324 1991 674 677
36. S. Hernandez-Diaz, M.M. Werler, A.M. Walker, and A.A. Mitchell Neural tube defects in relation to use of folic acid antagonists during pregnancy Am J Epidemiol 153 2001 961 968
37. S. Matalon, S. Schechtman, G. Goldzweig, and A. Ornoy The teratogenic effect of carbamazepine: a meta-analysis of 1255 exposures Reprod Toxicol 16 2002 9 17
38. D. Lindhout, and D. Schmidt In-utero exposure to valproate and neural tube defects Lancet 2 1986 1392 1393
39. R. Canger, D. Battino, and M. Canerini Malformations in offspring of women with epilepsy: a prospective study Epilepsia 40 1999 1231 1236
40. J.G. Omtzigt, F.J. Los, D.E. Grobbee, L. Pijpers, M.G. Jahoda, and H. Brandenburg The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort Neurology 42 4 Suppl 5 1992 119 125
41. F.J. Vajda, T.J. O'Brien, A. Hitchcock, J. Graham, and C. Lander The Australian registry of anti-epileptic drugs in pregnancy: experience after 30 months J Clin Neurosci 10 2003 543 549
42. G. Mawer, J. Clayton-Smith, H. Coyle, and S. Kivity Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate Seizure 11 2002 512 518
43. K. Wide, B. Winbladh, and B. Kallen Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: a nation-wide, population-based register study Acta Paediatr 93 2004 174 176
44. L.B. Holmes, D.F. Wyszynski, and E. Lieberman The AED (antiepileptic drug) pregnancy registry: a 6-year experience Arch Neurol 61 2004 673 678
45. L. Holmes, D. Wyszynski, and R. Mittendorf Evidence for an increased risk of birth defects in the offspring of women exposed to valproate: findings from the AED pregnancy registry Am J Obstet Gynecol 187 2002 5137
46. Lamotrigine pregnancy registry, interim report, 9/1/92-9/30/03 2004 GlaxoSmithKline Durham, NC
47. A. Sabers, M. Dam, B. Rogvi-Hansen, J. Boas, P. Sidenius, and F.M. Laue Epilepsy and pregnancy: lamotrigine as main drug used Acta Neurol Scand 109 2004 9 13
48. G. Montouris Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry Epilepsy Behav 4 2003 310 317
49. L. Long Levetiracetam monotherapy during pregnancy: a case series Epilepsy Behav 4 2003 447 448
50. R. Meischenguiser, C.H. D'Giano, and S.M. Ferraro Oxcarbazepine in pregnancy: clinical experience in Argentina Epilepsy Behav 5 2004 163 167
51. T. Kondo, S. Kaneko, Y. Amano, and I. Egawa Preliminary report on teratogenic effects of zonisamide in the offspring of treated women with epilepsy Epilepsia 37 2004 1242 1244
52. G. Montouris, G. Creasy, A. Khan, and W. Neto Pregnancy outcomes in topiramate-treated women Epilepsia 44 Suppl 9 2003 290
53. E. Pschirrer, and M. Monga Seizure disorders in pregnancy Obstet Gynecol Clin 28 2001 601 611
54. F. Malone, and M. D'Alton Drugs in pregnancy: anticonvulsants Semin Perinatol 21 1997 114 123
55. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists Seizure disorders in pregnancy Inte J Gynecol Obstet 56 1997 279 286
56. A. Leavitt, M. Yerby, N. Robinson, C. Sells, and D. Erickson Epilepsy in pregnancy: developmental outcome of offspring at 12 months Neurology 42 4 Suppl 5 1992 141 143
57. M. Ganstrom, and E. Gaily Psychomotor development in children of mothers with epilepsy Neurology 42 Suppl 5 1992 144 148
58. S. Koch, K. Titze, R. Zimmerman, M. Schroder, U. Lehmkuhl, and H. Rauh Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents Epilepsia 40 1999 1237 1243
59. L.V. Dansky, and R.H. Finnell Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: human studies Reprod Toxicol 5 1991 301 335
60. F. Majewski, M. Steger, B. Richter, J. Gill, and F. Rabe The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents Int J Biol Res Pregnancy 2 1981 37 45
61. L.B. Holmes, P.B. Rosenberger, E.A. Harvey, S. Khoshbin, and L. Ryan Intelligence and physical features of children of women with epilepsy Teratology 61 2000 196 202
62. J. Reinisch, S. Sanders, E. Mortensen, and D. Rubin In utero exposure to phenobarbital and intelligence deficits in adult men JAMA 724 1995 1518 1525
63. D. Vanoverloop, R. Schnell, E. Harvey, and L. Holmes The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age Neurotoxicol Teratol 14 1992 329 335
64. A. Ornoy, and E. Cohen Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy Arch Dis Child 75 1996 517 520
65. N. Adab, A. Jacoby, D. Smith, and D. Chadwick Additional educational needs in children born to mothers with epilepsy J Neurol Neurosurg Psychiatry 70 2001 15 21
66. E. Gaily, E. Kantola-Sorsa, V. Hiilesmaa, M. Isoaho, R. Matila, and M. Kotila Normal intelligence in children with prenatal exposure to carbamazepine Neurology 62 2004 28 32
67. N. Adab, C. Tudor-Smith, J. Vinten, and J. Winterbottom A systematic review of long term developmental outcomes in children exposed to antiepileptic drugs in utero Epilepsia 43 Suppl 7 2002 230 231
68. G. Leonard, E. Andermann, and A. Ptito Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring [abstract] Epilepsia 38 Suppl 3 1997 170
69. K. Meador Cognitive effects of epilepsy and of antiepileptic medications E. Wyllie The treatment of epilepsy: principles and practice 2001 Williams and Wilkins Philadelphia 1215 1226
70. D. Battino, S. Kaneko, and E. Andermann Intrauterine growth in the offspring of epileptic women: a prospective multicenter study Epilepsy Res 36 1999 53 60
71. J. Annegers, W. Hauser, L. Elveback, V. Anderson, and L. Kurland Congenital malformations and seizure disorders in the offspring of parents with epilepsy Int J Epidemiol 7 1978 241 247
72. R. Ottman, J. Annegers, W. Hauser, and L. Kurland Higher risk of seizures in offspring of mothers than fathers with epilepsy Am J Hum Genet 43 1988 357 364
73. M. Yerby, and M. Cawthon Fetal death, malformations and infant mortality in infants of mothers with epilepsy Epilepsia 37 Suppl 5 1996 98
74. M. Yerby, and S. Collins Teratogenecity of antiepileptic drugs J. Engel T. Pedley Epilepsy, a comprehensive textbook 1997 Lippincott-Raven Philadelphia 1195 1203
75. L. Dansky, D. Rosenblatt, and E. Andermann Mechanisms of teratogenesis: folic acid and antiepileptic therapy Neurology 42 1992 32 42
76. C. Wegner, and H. Nau Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanisms of teratogenesis Neurology 42 Suppl 5 1992 17 24
77. L. Botto, C. Moore, M. Khoury, and J. Erickson Medical progress: neural-tube defects N Engl J Med 341 1999 1509 1519
78. MRC Vitamin Study Research Group Prevention of neural-tube defects: results of the Medical Researdh Council Vitamin Study Lancet 338 1991 131 137
79. J. Hall, and F. Solehdin Folic acid for the prevention of congential anomalies Eur J Pediatr 157 1998 445 450
80. S. Hernandez-Diaz, M. Werler, and A. Walker Folic acid antagonists during pregnancy and the risk of birth defects N Engl J Med 343 2000 1608 1614
81. M. Nambisan, D.F. Wyszynski, and L.B. Holmes No evidence of a protective effect due to periconceptional folic acid (PCFA) intake on risk for congenital anomalies in the offspring of mothers exposed to antiepileptic drugs (AEDs) Birth Defects Res 67 2003 5
82. Seizure disorders in pregnancy. ACOG education bulletin no. 231. Gynecologists AcoOa; 1996.
83. B.A. Buehler, V. Rao, and R.H. Finnell Biochemical and molecular teratology of fetal hydantoin syndrome Pediatric Neurogenetics 12 1994 741 748
84. C.E. Pippenger Pharmacology of neural tube defects Epilepsia 44 2003 24 32
85. O. Devinsky, and M. Yerby Women with epilepsy Neurol Clin 12 1994 479 495
86. K. Gee, L. McCauley, and N. Lan A putatative receptor for neurosteroids on the GABA receptor complex: the pharmacological properties and therapeutic potential of epalons Crit Rev Neurobiol 1995 205 207
87. D. Cantrell Epilepsy and pregnancy: a study of seizure frequency and patient demographics Epilepsia 38 Suppl 8 1997 231
88. M. Yerby, and S. Collins Pregnancy and the mother J. Engel T. Pedley Epilepsy, A comprehensive textbook 1997 Lippincott-Raven Philadelphia 2027 2035
89. D. Schmidt, R. Canger, and G. Avanzini Change of seizure frequency in pregnant epileptic women J Neurol Neurosurg Psychiatry 46 1983 751 755
90. D. Stumpf, and M. Frost Seizures, anticonvulsants, and pregnancy Am J Dis Child 132 1978 746 748
91. H. Minkoff, R. Schaffer, I. Delke, and A. Grunevaum Diagnosis of intracranial hemorrhage in utero after a maternal seizure Obstet Gynecol 65 Suppl 1985 22S 24S
92. K. Teramo, V. Hiilesmaa, and A. Bardy Fetal heart rate during a maternal grand mal epileptic seizure J Perinat Med 7 1979 3 5
93. K. Teramo, and V. Hiilesmaa Pregnancy and fetal complications in epileptic pregnancies: review of the literature D. Janz L. Bossi M. Dam Epilepsy, pregnancy and the child 1982 Raven Press New York 53 59
94. M. Nei, S. Daly, and J. Liporace A maternal complex partial seizure in labor can affect fetal heart rate Neurology 51 1998 904 906
95. M. Pearlman, J. Tintinalli, and R. Lorenz Blunt trauma during pregnancy N Engl J Med 323 1990 1609 1613
96. P.B. Pennell Antiepileptic drug pharmacokinetics during pregnancy and lactation Neurology 61 6 Suppl 2 2003 S35 S42
97. M.S. Yerby The use of anticonvulsants during pregnancy Semin Perinatol 25 2001 153 158
98. I. Ohman, S. Vitols, and T. Tomson Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonata and during lactation Epilepsia 41 2000 709 713
99. P.B. Pennell, D.J. Newport, Z.N. Stowe, S.L. Helmers, J.Q. Montgomery, and T.R. Henry The impact of pregnancy and childbirth on the metabolism of lamotrigine Neurology 62 2004 292 295
100. T.A. Tran, I.E. Leppik, K. Blesi, S.T. Sathanandan, and R. Remmel Lamotrigine clearance during pregnancy Neurology 59 2002 251 255
101. P.B. Pennell, D.J. Newport, A. Koganti, J.Q. Montgomery, A.J. Beach, and M.L. Newman The course of altered valproate metabolism during pregnancy Neurology 62 Suppl 5 2004 A351 A352
102. M.S. Yerby, P.N. Friel, and K. McCormick Antiepileptic drug disposition during pregnancy Neurology 42 4 Suppl 5 1992 12 16
103. M.S. Yerby Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation Epilepsia 44 2003 33 40
104. K. Fonager, H. Larsen, L. Pedersen, and H.T. Sorensen Birth outcomes in women exposed to anticonvulsant drugs Acta Neurol Scand 101 2000 289 294
105. A. Howe, D. Oakes, P. Woodman, and W. Webster Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy Epilepsia 40 1999 980 984
106. G. Srinivasan, R.A. Seeler, and A. Tiruvury Maternal anticonvulsant therapy and hemorrhagic disease of the newborn Obstet Gynecol 59 1982 250 252
107. M.S. Yerby, P. Kaplan, and T. Tran Risks and management of pregnancy in women with epilepsy Cleve Clin J Med 71 Suppl 2 2004 S25 S37
108. K.B. Nelson, and J.H. Ellenber Maternal seizure disorder, outcomes of pregnancy, and neurologic abnormalities in the children Neurology 32 1982 1247 1254
109. M. Cornelissen, R. Steegers-Theunissen, L. Kollee, T. Eskes, G. Vogels-Mentink, and K. Motohara Increased incidence of neonatal vitamin K deficiency resulting from maternal anticonvulsant therapy Am J Obstet Gynecol 168 3 Pt 1 1993 923 928
110. M. Cornelissen, R. Steegers-Theunissen, L. Kollee, T. Eskes, K. Motohara, and L. Monnens Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency Am J Obstet Gynecol 168 3 Pt 1 1993 884 888
111. A. Delgado-Escueta, and D. Janz Consensus guidelines: preconception counseling, management, and care of the pregnant woman with epilepsy Neurology 42 1992 149 160
112. J.M. Katz, and O. Devinsky Primary generalized epilepsy: a risk factor for seizures in labor and delivery? Seizure 12 2003 217 219
113. B. Krauer, and F. Krauer Drug kinetics in pregnancy Clin Pharmacokinet 2 1977 167 181
114. C. Fox, and T. Betts How much risk does a woman with active epilepsy pose to her newborn child in the puerperium? A pilot study Seizure 86 1999 367 369
115. Report of the quality of standards subcommittee of the American Academy of Neurology Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients - summary statement Neurology 47 1996 600 602
116. K. Moore The developing human: clinically oriented embryology 4th edition 1988 WB Saunders Philadelphia